Methicillin-Resistant Staphylococcus Aureus Clinical Trial
Methicillin resistant Staphylococcus aureus (MRSA) which is one of the principal multidrug
resistant organisms found in the hospitals all over the world, has recently emerged in the
community. However, for the moment (2002), the hospital remains the principal reservoir of
MRSA so far and the patients discharged with a MRSA carriage can be the source of MRSA
spreading in the community. In particular patients admitted to home care (HC) from acute
care facilities represent a patient group with a high risk of MRSA carriage and of being the
source of MRSA spreading in the community. The objective of this study is to determine
whether HC patients are effectively a MRSA reservoir and a source for MRSA spreading in the
community.
For that, from February 2003 to March 2004 any adult patient (except obstetric patient)
(approximately 3360 patients for 16 HC settings), will be screened [nasal and skin lesion
(if any) swabs] for MRSA carriage within the 48 h before his/her transfer. The patients
found to be MRSA carriers will be visited by a physician who will ask patients as well as
family members to participate in the study. Each patient and each family member who will
have given agreement to participate, will be sampled (nasal swab for both patient and family
members, and skin lesion swab for the patients with skin lesions) every month for 12 months
by the nurse of the HC setting in which the patient will have been admitted. As soon as the
patient will be discharged from HC setting and if the 12 month survey is not finished,
patient and family member swab sampling will be performed by the nurse of the research team
(NRT) every 3 months until the end of the survey period. These swabs will be transmitted by
the NRT to the research center and analyze by the microbial technician of the research
center. The bacteriological survey will be accompanied with an epidemiological survey in
order to determine the risk factors for a long term MRSA carriage in the patients admitted
in HC and also the risk factors for transmitting MRSA to their family.
This multi-centre and multi-investigator study will be performed over a period of 32 months
(1 month to prepare the study, 13 months to screen patients with regard to MRSA carriage
before their transfer from acute care settings into HC settings, 12 months to survey HC
patients and their family members and 6 months to analyze data and prepare publications).
Such a study will provide us with descriptive and quantitative data on MRSA strains
introduced in the community by HC patients. From the analysis of risk factors of MRSA
transmission from these patients to their family members, suggestions to limit this
transmission might be drawn.
n/a
Observational Model: Defined Population, Time Perspective: Longitudinal
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05529173 -
Povidone-Iodine for Nasal Decolonization
|
Phase 4 | |
| Completed |
NCT00980980 -
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
|
N/A | |
| Recruiting |
NCT03412500 -
Vancomycin Dosage Adjustment for MRSA Infections
|
Phase 4 | |
| Recruiting |
NCT02566928 -
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
|
Phase 4 | |
| Terminated |
NCT01196169 -
Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty
|
Phase 4 | |
| Completed |
NCT00996112 -
Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections
|
N/A | |
| Not yet recruiting |
NCT00773864 -
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
|
N/A | |
| Not yet recruiting |
NCT00773799 -
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community
|
N/A | |
| Completed |
NCT01350479 -
Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers
|
N/A | |
| Recruiting |
NCT03637400 -
Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
|
Phase 2 | |
| Completed |
NCT01200654 -
Population Pharmacokinetics of Linezolid
|
Phase 4 | |
| Withdrawn |
NCT00856089 -
Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization
|
Phase 4 | |
| Recruiting |
NCT04171817 -
Animal-Assisted Visitation Program Chlorhexidine Trial
|
Phase 4 | |
| Completed |
NCT00324922 -
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis
|
Phase 3 | |
| Completed |
NCT02814916 -
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
|
Phase 3 | |
| Withdrawn |
NCT00713674 -
Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx
|
N/A | |
| Not yet recruiting |
NCT05632315 -
PMT for MDRO Decolonization
|
Phase 2 | |
| Completed |
NCT03886623 -
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
|
N/A | |
| Not yet recruiting |
NCT01356472 -
Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
|
Phase 4 | |
| Completed |
NCT01141101 -
Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
|
N/A |